Related Experiment Video

Updated: Jul 18, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Childhood immunization rates in Louisiana: trends from 1995-2004

Joanna Eavey1, Ruben Tapia, Theresa Sokol

  • 1Louisiana Department of Health and Hospitals, USA.

The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
|December 6, 2006
PubMed

Insights

Childhood immunization rates in Louisiana improved between 1995-2003, but coverage varied by vaccine series and age. Discrepancies were noted for simultaneously administered vaccines, suggesting areas for physician improvement.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Immunization is crucial for preventing infectious diseases in children.
  • The Centers for Disease Control and Prevention (CDC) recommends vaccines against 11 diseases for children.
  • Understanding childhood immunization coverage is vital for public health initiatives.

Purpose of the Study:

  • To examine childhood immunization rates in Louisiana from 1995-2003.
  • To compare Louisiana's rates with neighboring states and national averages.
  • To identify factors affecting immunization coverage and suggest improvements.

Main Methods:

  • Analysis of immunization records for Louisiana children aged 19-35 months.
  • Comparison of coverage rates across different vaccine series and age groups.
  • Evaluation of vaccination timing and simultaneous administration practices.

Main Results:

  • Louisiana's immunization coverage rates showed improvement over the study period, despite a dip in 2001.
  • Coverage varied based on the number of vaccines in a series and the age of administration.
  • Discrepancies were observed in the coverage of vaccines recommended for simultaneous administration.

Conclusions:

  • Childhood immunization rates in Louisiana have improved but require continued monitoring.
  • Vaccine series complexity and timing impact overall coverage.
  • Physicians can implement targeted strategies to address coverage gaps, particularly for simultaneously administered vaccines.

More Related Videos

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...